Drug Trials Snapshots: JAYPIRCA (pirtobrutinib)

JAYPIRCA is a Bruton tyrosine kinase (BTK) inhibitor that is used to treat a form of cancer called mantle cell lymphoma (MCL). It is to be used in adult patients whose cancer came back after or did not respond to at least two prior treatment regimens which included a BTK inhibitor. https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-jaypirca